Table of Contents
Historical Data, Premium Insights, Market Dynamic, Analysis and Projection, By Product, Analysis and Projection, By Application, Analysis and Projection, By End-Use, Analysis and Projection, By Regional Analysis, Competitive Landscape, Company Profiles, Market Revenue, Sale & Price Analysis
Related Topics
Cardiovascular Diagnostic and Monitoring Market Size Heat Recovery Ventilator Market Size Airflow and Zone Controls Equipment Market Size Geopipes Market SizeGlobal Chronic Kidney Disease (CKD) Nutritional Supplements Market Size to Exceed USD 5.20 Billion by 2033
According to a research report published by Spherical Insights & Consulting, The Global Chronic Kidney Disease (CKD) Nutritional Supplements Market Size is Expected to Grow from USD 3.56 Billion in 2023 to USD 5.20 Billion by 2033, at a CAGR of 3.86% during the forecast period 2023-2033.
Browse 210 market data Tables and 45 Figures spread through 190 Pages and in-depth TOC on the Global Chronic Kidney Disease (CKD) Nutritional Supplements Market Size, Share, and COVID-19 Impact Analysis, By Nutrition Type (Amino Acid Supplements [Alpha-Ketoanalogue Supplements, Alpha Lipoic Acid Supplements, and Others], Vitamin & Mineral Supplements, Probiotics, Prebiotics / Fibers, and Others), By CKD Stage (Pre-Dialysis Stage 1-2, Pre-Dialysis Stage 3-5, Dialysis, and End-stage Renal Disease), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Stores), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033.
The chronic kidney disease (CKD) nutritional supplements market is the business involved in the creation, manufacture, and distribution of therapeutic nutritional supplements that cater to the needs of people with chronic kidney disease (CKD). The supplements are used to control kidney function, slow disease progression, and counteract malnutrition resulting from dietary limitations and impaired kidney function. Furthermore, the world chronic kidney disease (CKD) nutritional supplements market is motivated by the growth in CKD prevalence, rising awareness of renal nutrition, and enhanced demand for specialty supplements. Development in medical nutrition, rising healthcare spending, favorable government policies, and a growing population of geriatric patients accelerate market growth further. The move towards personalized and plant-based supplements also boosts market growth. However, the high costs, limited awareness, strict regulations, reimbursement challenges, restricted product availability, and patient compliance issues in low-income regions are key restraints for the growth of the market.
The vitamin & mineral supplements segment accounted for the largest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period.
On the basis of the nutrition type, the global chronic kidney disease (CKD) nutritional supplements market is divided into amino acid supplements, vitamin & mineral supplements, probiotics, prebiotics/fibers, and others. The amino acid supplements are divided into alpha-ketoanalogue supplements, alpha-lipoic acid supplements, and others. Among these, the vitamin & mineral supplements segment accounted for the largest share in 2023 and is anticipated to grow at a significant CAGR during the forecast period. The segmental growth is expanded to the high demand for essential nutrients in CKD patients, increasing awareness of nutritional deficiencies, and growing recommendations from healthcare professionals. Rising adoption of personalized nutrition, improved supplement formulations, and expanding availability further drive its significant CAGR during the forecast period.
The end-stage renal disease segment accounted for the largest share in 2023 and is anticipated to grow at a remarkable CAGR during the forecast period.
On the basis of the CKD stage, the global chronic kidney disease (CKD) nutritional supplements market is divided into pre-dialysis stage 1-2, pre-dialysis stage 3-5, dialysis, and end-stage renal disease. Among these, the end-stage renal disease segment accounted for the largest share in 2023 and is anticipated to grow at a remarkable CAGR during the forecast period. The segmental growth is attributed to the rising prevalence of ESRD, increasing dialysis and transplant cases, and higher nutritional requirements for patients. Growing awareness, advancements in specialized supplements, and expanding healthcare access further drive the segment’s remarkable CAGR during the forecast period.
The hospital pharmacies segment accounted for the greatest share in 2023 and is anticipated to grow at a substantial CAGR over the forecast period.
On the basis of the distribution channel, the global chronic kidney disease (CKD) nutritional supplements market is divided into hospital pharmacies, retail pharmacies, and online stores. Among these, the hospital pharmacies segment accounted for the greatest share in 2023 and is anticipated to grow at a substantial CAGR over the forecast period. The segmental growth is attributed to the rising number of CKD patients, increased hospital visits for treatment, and easy access to prescribed nutritional supplements. Strong healthcare infrastructure, trusted product availability, and growing collaborations between hospitals and supplement manufacturers further drive its substantial CAGR over the forecast period.
North America is projected to hold the largest share of the global chronic kidney disease (CKD) nutritional supplements market over the forecast period.
North America is projected to hold the largest share of the global chronic kidney disease (CKD) nutritional supplements market over the forecast period. The regional growth is attributed to the high prevalence of CKD, advanced healthcare infrastructure, and the strong presence of key market players. Increasing awareness, favorable reimbursement policies, rising healthcare expenditure, and growing adoption of specialized nutritional therapies further contribute to the region’s significant market share during the forecast period.
Asia Pacific is expected to grow at the fastest CAGR growth of the global chronic kidney disease (CKD) nutritional supplements market during the forecast period. The regional growth is attributed to the rising prevalence of CKD, increasing healthcare investments, and growing awareness about nutritional management. Expanding healthcare infrastructure, a large aging population, government initiatives, and the availability of cost-effective supplements further drive the region’s rapid market expansion during the forecast period.
Company Profiling
Major vendors in the global chronic kidney disease (CKD) nutritional supplements market are Abbott Laboratories, Ajanta Pharma Limited, Fresenius Kabi AG, Hexagon Nutrition Limited, Mankind Pharma Ltd., Nestlé S.A., Nutricia Limited (Danone S.A.), PRINE Health MSO, LLC, RPG Life Sciences Limited, and others.
Key Target Audience
Recent Development
Market Segment
This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global chronic kidney disease (CKD) nutritional supplements market based on the below-mentioned segments:
Global Chronic Kidney Disease (CKD) Nutritional Supplements Market, By Nutrition Type
Global Chronic Kidney Disease (CKD) Nutritional Supplements Market, By CKD Stage
Global Chronic Kidney Disease (CKD) Nutritional Supplements Market, By Distribution Channel
Global Chronic Kidney Disease (CKD) Nutritional Supplements Market, By Regional
May 2025 - The Global Chronic Kidney Disease Treatment Market Size is Expected to Grow from USD 33.20 Billion in 2023 to USD 47.99 Billion by 2033, at a CAGR of 3.75% during the forecast period 2023-2033
May 2025 - The Global Chronic Kidney Disease Market Size is Expected to Grow from USD 38.30 Billion in 2023 to USD 66.65 Billion by 2033, at a CAGR of 5.70% during the forecast period 2023-2033
May 2025 - The Global Chronic Kidney Disease (CKD) Drug Market Size is Expected to Grow from USD 14.2 Billion in 2023 to USD 20.80 Billion by 2033, at a CAGR of 3.89% during the forecast period 2023-2033
We have received your message and would like to thank you for writing to us. If your inquiry is urgent, please use the telephone number listed below to talk to one of our staff members. Otherwise, we will reply by email as soon as possible.
+1 303 800 4326 +91 9561448932 emailsales@sphericalinsights.com
